1. Chen, Jianxiong, Duan, Shiyu, Wang, Yulu, Zheng, Haoxuan, Zhou, Jun. 2024. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration. In Nature communications, 15, 4969. doi:10.1038/s41467-024-49221-0. https://pubmed.ncbi.nlm.nih.gov/38862489/
2. Philips, Mari-Anne, Vikeså, Jonas, Luuk, Hendrik, Kõks, Sulev, Nielsen, Finn C. . Characterization of MYG1 gene and protein: subcellular distribution and function. In Biology of the cell, 101, 361-73. doi:10.1042/BC20080086. https://pubmed.ncbi.nlm.nih.gov/19014353/
3. Philips, Mari-Anne, Kingo, Külli, Karelson, Maire, Silm, Helgi, Kõks, Sulev. 2010. Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1. In BMC medical genetics, 11, 56. doi:10.1186/1471-2350-11-56. https://pubmed.ncbi.nlm.nih.gov/20377893/
4. Kingo, Külli, Philips, Mari-Anne, Aunin, Eerik, Vasar, Eero, Kõks, Sulev. 2006. MYG1, novel melanocyte related gene, has elevated expression in vitiligo. In Journal of dermatological science, 44, 119-22. doi:. https://pubmed.ncbi.nlm.nih.gov/16996721/
5. Han, Xiaodan, Li, Aili, Wang, Wei, Wang, Chen, Huang, Guojin. 2021. MYG1 promotes proliferation and inhibits autophagy in lung adenocarcinoma cells via the AMPK/mTOR complex 1 signaling pathway. In Oncology letters, 21, 334. doi:10.3892/ol.2021.12595. https://pubmed.ncbi.nlm.nih.gov/33692866/
6. Philips, Mari-Anne, Abramov, Urho, Lilleväli, Kersti, Kõks, Sulev, Vasar, Eero. 2009. Myg1-deficient mice display alterations in stress-induced responses and reduction of sex-dependent behavioural differences. In Behavioural brain research, 207, 182-95. doi:10.1016/j.bbr.2009.10.005. https://pubmed.ncbi.nlm.nih.gov/19818808/
7. Liu, Xuming, Zhu, Yurong, Huang, Wenqing, Long, Xiaoli, Zhou, Jun. 2025. MYG1 interacts with HSP90 to promote breast cancer progression through Wnt/β-catenin and Notch signaling pathways. In Experimental cell research, 446, 114448. doi:10.1016/j.yexcr.2025.114448. https://pubmed.ncbi.nlm.nih.gov/39956425/
8. Dwivedi, Mitesh, Laddha, Naresh C, Begum, Rasheedunnisa. 2013. Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients. In Journal of dermatological science, 71, 195-202. doi:10.1016/j.jdermsci.2013.04.026. https://pubmed.ncbi.nlm.nih.gov/23706493/
9. Traks, T, Keermann, M, Karelson, M, Kõks, S, Kingo, K. 2018. Polymorphisms in melanocortin system and MYG1 genes are associated with vitiligo. In Journal of the European Academy of Dermatology and Venereology : JEADV, 33, e65-e67. doi:10.1111/jdv.15195. https://pubmed.ncbi.nlm.nih.gov/30051642/
智鼠故事 
